Literature DB >> 7483782

Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum.

S Liu1, G Song, Y Xu, W Yang, D P McManus.   

Abstract

We report the cloning, by polymerase chain reaction (PCR), of a cDNA encoding a Schistosoma japonicum (Chinese) 26 kDa glutathione-S-transferase (GST) (Sjc26GST), expression of the cDNA, affinity purification of the recombinant GST and its vaccine efficacy in outbred NIH mice using Freund's as adjuvant. The most striking feature of the vaccination experiments was the pronounced reduction in the number of eggs in the livers and spleens of immunized mice. A relatively low but significant level of protection in terms of reduced worm viability against challenge infection was also observed. Further, the level of anti-Sjc26GST antibody in immunized mice was significantly higher than in control mice at week 6 post-challenge infection. These results closely mirror the protection conferred by immunization of animals with the 28 kDa GST of S. mansoni (Sm28) where a reduction in worm viability, worm fecundity and egg-hatching ability have been reported following challenge with S. mansoni. In terms of developing a vaccine against schistosomiasis japonica, immunization with Sjc26GST can provide two complementary goals in human or animal populations--some reduction in worm burden following exposure to infection or reinfection, and an anti-disease effect through reduction of pathology by a decrease in worm fecundity, with this direct effect also affecting the transmission of S. japonicum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483782     DOI: 10.1016/0264-410x(94)00045-o

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Construction, purification, and evaluation of multivalent DNA vaccine against Schistosoma japonicum.

Authors:  Lu Zhu; Hai-Feng Liu; Ming-Bo Lu; Quan-Ke Long; You-En Shi; Long-Jiang Yu
Journal:  Parasitol Res       Date:  2010-09-18       Impact factor: 2.289

2.  Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum.

Authors:  R Zhang; A Yoshida; T Kumagai; H Kawaguchi; H Maruyama; T Suzuki; M Itoh; M El-Malky; N Ohta
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.

Authors:  J J Lee; K A Sinha; J A Harrison; R D de Hormaeche; G Riveau; R J Pierce; A Capron; R A Wilson; C M Khan
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Immunogenicity of self-adjuvanticity oral vaccine candidate based on use of Bacillus subtilis spore displaying Schistosoma japonicum 26 KDa GST protein.

Authors:  Li Li; Xuchu Hu; Zhongdao Wu; Shiqiu Xiong; Zhenwen Zhou; Xiaoyun Wang; Jin Xu; Fangli Lu; Xinbing Yu
Journal:  Parasitol Res       Date:  2009-09-16       Impact factor: 2.289

Review 5.  Emerging and reemerging helminthiases and the public health of China.

Authors:  P J Hotez; F Zheng; X Long-qi; C Ming-gang; X Shu-hua; L Shu-xian; D Blair; D P McManus; G M Davis
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

6.  Enhancement of protective efficacy through adenoviral vectored vaccine priming and protein boosting strategy encoding triosephosphate isomerase (SjTPI) against Schistosoma japonicum in mice.

Authors:  Yang Dai; Xiaoting Wang; Jianxia Tang; Song Zhao; Yuntian Xing; Jianrong Dai; Xiaolin Jin; Yinchang Zhu
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens.

Authors:  Xindong Xu; Dongmei Zhang; Wei Sun; Qingfeng Zhang; Jingjing Zhang; Xiangyang Xue; Luhui Shen; Weiqing Pan
Journal:  BMC Infect Dis       Date:  2009-05-06       Impact factor: 3.090

8.  Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.

Authors:  Guidenn Sulbarán; Oscar Noya; Beatríz Brito; Diana E Ballén; Italo M Cesari
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

Review 9.  Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

Authors:  Rachel Stephenson; Hong You; Donald P McManus; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2014-09-02

10.  PAMAM-Lys, a novel vaccine delivery vector, enhances the protective effects of the SjC23 DNA vaccine against Schistosoma japonicum infection.

Authors:  Xiaoting Wang; Yang Dai; Song Zhao; Jianxia Tang; Hongjun Li; Yuntian Xing; Guoli Qu; Xinsong Li; Jianrong Dai; Yinchang Zhu; Xueguang Zhang
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.